66536-81-0

Basic information

• Product Name: Uridine-5-oxyacetic acid methyl ester
• Synonyms: Uridine-5-oxyacetic acid methyl ester;methyl uridin-5-yloxyacetate
• CAS NO: 66536-81-0
• Molecular Formula: C12H16N2O9
• Molecular Weight: 332.26344
• Mol File: 66536-81-0.mol
• Article Data: 0

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: 1.65g/cm³
• Refractive Index: 1.622
• CAS DataBase Reference: Uridine-5-oxyacetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Uridine-5-oxyacetic acid methyl ester(66536-81-0)
• EPA Substance Registry System: Uridine-5-oxyacetic acid methyl ester(66536-81-0)

Safety Data

• Hazardous Substances Data: 66536-81-0(Hazardous Substances Data)

Usage

Description

Uridine-5-oxyacetic acid methyl ester is a methyl ester of uridine, a nucleoside composed of the sugar moiety ribose and the pyrimidine base uracil. It is characterized by the substitution of a methoxycarbonylmethoxy group at the 5-position on the uracil ring, which imparts unique chemical and biological properties to the molecule.

Uses

Used in Pharmaceutical Industry:
Uridine-5-oxyacetic acid methyl ester is used as a pharmaceutical intermediate for the synthesis of various nucleoside analogs and antiviral agents. Its unique structure allows for the development of compounds with enhanced antiviral activity and reduced toxicity, making it a valuable component in the design of new therapeutic agents.
Used in Biochemical Research:
In the field of biochemical research, Uridine-5-oxyacetic acid methyl ester serves as a valuable tool for studying the mechanisms of nucleic acid synthesis, replication, and repair. Its ability to interact with enzymes and other biomolecules involved in these processes can provide insights into the regulation of cellular functions and the development of novel therapeutic strategies.
Used in Drug Delivery Systems:
Uridine-5-oxyacetic acid methyl ester can be employed in the development of drug delivery systems, particularly for nucleoside-based therapeutics. Its unique chemical properties may enable the design of targeted delivery systems that improve the bioavailability, stability, and efficacy of nucleoside drugs, ultimately enhancing their therapeutic potential.

InChI:InChI=1/C12H16N2O9/c1-21-7(16)4-22-5-2-14(12(20)13-10(5)19)11-9(18)8(17)6(3-15)23-11/h2,6,8-9,11,15,17-18H,3-4H2,1H3,(H,13,19,20)/t6-,8-,9-,11-/m1/s1